Buprenorphine for Cancer Pain

Clinical trial NCT05910190 · UNKNOWN

Trial details

NCT number: NCT05910190
Sponsor: Fox Chase Cancer Center
Status: UNKNOWN
Phase: Phase 4
Study type: INTERVENTIONAL

Cancer-Related Pain

Start date: 2022-08-10
Primary completion: 2024-10-10
Enrollment: 50

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.